. * * window.aa needs to exist and be usable by ANY module's script, * however early it runs - main-nav's script, for one, runs near * the top of

91̽»¨

, well before the real search-insights.js * so the download * begins as early as before. Repeat calls share the same downloads, a * failed load is retried on the next call, and the versions / SRI * hashes live only here. * * Algolia Insights is unaffected: window.aa above is still created in * on every page and queues events until search-insights loads. * * window.loadAlgoliaLibs({ priority: 'high' }) (Oct 2026): used by the * /search page, where the first results wait on these libraries. Chrome * gives async scripts low priority, behind images and fonts; this asks * for high instead (fetchpriority). Only the first call for a library * sets its priority - later calls share that download. */ (function (win, doc) { var LIBS = [ { ready: function () { return !!win['algoliasearch/lite']; }, src: 'https://cdn.jsdelivr.net/npm/algoliasearch@5.52.1/dist/lite/builds/browser.umd.js', integrity: 'sha256-I2oYUIvhx1g6l4lTP+yoERbzLIHKzw4AKaBRQPwIeDY=' }, { ready: function () { return !!win.instantsearch; }, src: 'https://cdn.jsdelivr.net/npm/instantsearch.js@4.98.0/dist/instantsearch.production.min.js', integrity: 'sha256-ngmqZk4WBxUw257aMYZayyNBd983INngagv0jI6Ecfs=' } ]; function loadOne(lib, options) { if (lib.ready()) return Promise.resolve(); // One download per library, shared by every caller; reset on // failure so the next call retries just the library that failed. if (lib.pending) return lib.pending; lib.pending = new Promise(function (resolve, reject) { var script = doc.createElement('script'); script.src = lib.src; script.integrity = lib.integrity; script.crossOrigin = 'anonymous'; script.async = true; if (options && options.priority === 'high') script.setAttribute('fetchpriority', 'high'); script.onload = function () { lib.ready() ? resolve() : reject(new Error('Loaded but not available: ' + lib.src)); }; script.onerror = function () { script.remove(); reject(new Error('Could not load ' + lib.src)); }; doc.head.appendChild(script); }); lib.pending.catch(function () { lib.pending = null; }); return lib.pending; } win.loadAlgoliaLibs = function (options) { return Promise.all(LIBS.map(function (lib) { return loadOne(lib, options); })); }; })(window, document); . */ window.hsConversationsSettings = window.hsConversationsSettings || {}; window.hsConversationsSettings.loadImmediately = false; (function (win) { var EVENTS = ['pointerdown', 'keydown', 'touchstart', 'scroll', 'mousemove', 'wheel']; var done = false; /* 19 Oct 2026 - chat widget layout shift (field CLS). Phones fail Core Web Vitals on CLS (p75 ~0.2 site-wide in CrUX for months). Biggest cause found: HubSpot's chat container is fixed to the bottom-right corner and changes size - 100x96 launcher to 282x253 when the welcome message pops up (~5 s after load), and to full screen when a visitor opens the chat. Its top-left corner moves, so Chrome scores it as a layout shift: 0.088 per page view at 360x640 (0.044 at 412x850), on every page. Taps happen inside the chat iframe, so the parent page never sees the input and the open/close shifts count too. Fix: whenever the container's size changes it is made transparent for 400 ms (Chrome doesn't score shifts of invisible elements), then shown again at its new size. Tested on live io1001 at 360x640 in a cookie-less frame: the 0.088 shift no longer appears. The chat itself is unchanged - it just appears 0.4 s later at each resize. Relies on HubSpot's container id; if that changes this does nothing (no error). */ function cloakChatResizes() { var ID = 'hubspot-messages-iframe-container'; function watch(c) { if (c.getAttribute('data-bb-cloak')) return; c.setAttribute('data-bb-cloak', '1'); var last = c.offsetWidth + 'x' + c.offsetHeight, timer = null; new MutationObserver(function () { var size = c.offsetWidth + 'x' + c.offsetHeight; if (size === last) return; last = size; c.style.setProperty('opacity', '0', 'important'); clearTimeout(timer); timer = setTimeout(function () { c.style.removeProperty('opacity'); }, 400); }).observe(c, { attributes: true, attributeFilter: ['style', 'class'], subtree: true, childList: true }); } var found = document.getElementById(ID); if (found) { watch(found); return; } if (!document.body || !('MutationObserver' in win)) return; var mo = new MutationObserver(function () { var c = document.getElementById(ID); if (c) { mo.disconnect(); watch(c); } }); mo.observe(document.body, { childList: true }); setTimeout(function () { mo.disconnect(); }, 30000); } function loadWidget() { var api = win.HubSpotConversations; if (api && api.widget && api.widget.status && api.widget.status().loaded) return; try { cloakChatResizes(); } catch (e) {} if (api && api.widget) api.widget.load(); } function onFirstInteraction() { if (done) return; done = true; EVENTS.forEach(function (type) { win.removeEventListener(type, onFirstInteraction, { passive: true }); }); var start = function () { if (win.HubSpotConversations) loadWidget(); else (win.hsConversationsOnReady = win.hsConversationsOnReady || []).push(loadWidget); }; if ('requestIdleCallback' in win) win.requestIdleCallback(start, { timeout: 1500 }); else setTimeout(start, 200); } EVENTS.forEach(function (type) { win.addEventListener(type, onFirstInteraction, { passive: true }); }); })(window);

91̽»¨

Skip to main content
Complex cultures of human iPSC-derived neurons and glia to study the biology underlying myelination and neuroinflammation
Webinar

Complex cultures of human iPSC-derived neurons and glia to study the biology underlying myelination and neuroinflammation

In this webinar, our expert speaker explores how human iPSC-derived neuronal and glial cells can be combined to investigate cellular crosstalk underlying neuroinflammation and myelination, using glutamatergic neurons, astrocytes, microglia and oligodendrocyte-like cells.
Complex cultures of human iPSC-derived neurons and glia to study the biology underlying myelination and neuroinflammation

Mitzy Rios de Anda, PhD

Senior Scientist 

91̽»¨

Complex cultures of human iPSC-derived neurons and glia to study the biology underlying myelination and neuroinflammation
In this webinar, our expert speaker explores how human iPSC-derived neuronal and glial cells can be combined to investigate cellular crosstalk underlying neuroinflammation and myelination, using glutamatergic neurons, astrocytes, microglia and oligodendrocyte-like cells.
Complex cultures of human iPSC-derived neurons and glia to study the biology underlying myelination and neuroinflammation

Mitzy Rios de Anda, PhD

Senior Scientist 

91̽»¨

This webinar shows the development of defined human multi-cell in vitro systems that could be used to study neuron–glia interactions, immune activation and myelination in neurodegenerative disease research.

Neurodegenerative diseases are often studied from a neuron-centric perspective. However, glial cells actively shape disease progression, contributing to immune activation, synapse loss and demyelination.

To investigate these complex interactions in a human context, this webinar presents a CNS toolkit comprising human iPSC-derived glutamatergic neurons, astrocytes, microglia and oligodendrocyte-like cells. The session outlines co-culture strategies enabling the modelling of cellular crosstalk during physiological and pathological conditions.

In addition, the webinar highlights strategies to enhance oligodendrocyte maturation in monoculture through media optimisation, increasing the MBP-positive cell populations without requiring a neuron co-culture. A brief introduction to OPC-like cells also outlines their potential use to model OPC biology in vitro and to develop efficient remyelination-promoting therapies.

The webinar concludes with a live Q&A focused on experimental design considerations, selection of relevant cellular combinations, and integration of multi-cell human systems into translational research workflows.

Key learnings 

  • Why defined, reproducible human in vitro systems are critical for improving translatability in remyelination research and neurodegenerative drug discovery
  • How a human CNS toolkit of neurons, astrocytes, microglia and oligodendroglial cells can enable investigation of immune activation, remyelination mechanisms and disease-relevant cellular crosstalk
  • How human oligodendrocyte-like cells acquire mature morphology and upregulate MBP within 8 days, and how co-culture with glutamatergic neurons further enhances MBP expression
  • How systematic media optimisation can increase the proportion of MBP-positive oligodendrocyte-like cells without reliance on co-culture
  • What makes a defined neuron–microglia–astrocyte tri-culture a good starting point for functional, inflammatory and synaptic assay development
  • How human OPC-like cells model key progenitor features, including limited proliferation capacity and PDGFRA expression, and how maturation conditions drive transition towards a pre-myelinating oligodendrocyte state

Related pages

91̽»¨ Learn about our range of human iPSC-derived cells for research and drug discovery
Our platform Discover the cell coding platform behind our cells
Contact us Talk to us to learn more about our team and products